Brexit | New guidance documents from MHRA

New guidance documents_MHRA

Brexit | New guidance documents from MHRA

From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be the UK’s standalone medicines and medical devices regulator.

This month the UK’s medicines regulator has published two new guidance documents:

Stakeholders need to get ready for new rules.

Asphalion, an International Scientific and Regulatory Affairs Consultancy, offers regulatory solutions in the UK and can ease your path through this transition, assessing you on each step of the way. Contact us at london@asphalion.com

Asphanews 4 | News on Regulatory Affairs
Industrial Doctorate at Asphalion | Francisco Rodríguez